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Localization of the TIG3 Transglutaminase
Interaction Domain and Demonstration that the
Amino-Terminal Region Is Required for TIG3
Function as a Keratinocyte Differentiation Regulator
Ralph Jans1, Michael T. Sturniolo1 and Richard L. Eckert1
Tazarotene-induced gene 3 (TIG3) regulates keratinocyte terminal differentiation by activating type I
transglutaminase (TG1). TIG3 consists of an amino-terminal (N-terminal) segment, that encodes several
conserved motifs, and a carboxy-terminal (C-terminal) membrane-anchoring domain. By producing a series of
truncation mutants that remove segments of the N-terminal region, and monitoring the ability of each mutant to
co-precipitate TG1, function as a TG1 substrate, or functionally localize with TG1 in cells, we show that the TIG3
domain that interacts with TG1 is located within a TIG3 segment spanning amino acids 112–164. Although they
bind TG1, TIG3 mutants lacking the conserved N-terminal region drive apoptosis-like cell death characterized
by cell rounding, membrane blebbing, cytochrome c release, procaspase-3 and poly(ADP-ribose)polymerase
(PARP) cleavage, and reduced p53 and p21 levels. Compared with TIG3, these truncated mutants have an
increased tendency to associate with membranes. A mutant lacking the C-terminal membrane-anchoring
domain is inactive. These findings suggest that TIG3 interaction with TG1 does not require the N-terminal
conserved domains, that the TIG3 N-terminal region is required for TIG3-dependent keratinocyte differentia-
tion, that its removal converts TIG3 into a proapoptotic protein, and that this change in action of TIG3 is
associated with an intracellular redistribution.
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INTRODUCTION
Tazarotene-induced gene 3 (TIG3) is a low-molecular-weight
protein of 164 amino acids, originally identified in retinoid-
treated cultured epidermal keratinocytes (DiSepio et al.,
1998). In epithelial cancer cells, TIG3 acts as a class II tumor
suppressor to inhibit cell proliferation (Deucher et al., 2000),
an activity that requires association of TIG3 with membranes
(Deucher et al., 2000; Tsai et al., 2006). TIG3 has an important
role in normal human keratinocytes, where it regulates
keratinocyte survival by controlling type I transglutaminase
(TG1) activity (Sturniolo et al., 2003, 2005). Transglutaminases
comprise a family of enzymes that catalyze the formation of
covalent isopeptide bonds between proteins (Eckert et al.,
1997). TG1 is a unique transglutaminase, in that it possesses
an amino-terminal (N-terminal) lipid linkage that anchors it to
the inner surface of the plasma membrane, the location of
cornified envelope assembly (Phillips et al., 1993; Steinert
et al., 1996). TG1 activity is required for successful deposition
of the keratinocyte cornified envelope, a structure that is
assembled adjacent the inner surface of the plasma membrane
during the terminal stages of keratinocyte differentiation. The
cornified envelope, which consists of individual proteins that
are held together via interprotein covalent isopeptide bonds
(Rice and Green, 1977; Eckert et al., 1997; Kalinin et al.,
2002), is the major structure responsible for epidermal barrier
function (Eckert and Rorke, 1989; Eckert et al., 1993; Nemes
and Steinert, 1999; Steinert and Marekov, 1999). Lipids are
also covalently incorporated into this structure, thus rendering
it impermeable to water (Wertz et al., 1989).
Identifying factors that regulate TG1 level and activity is an
important topic, since TG1 activity is absolutely essential for
cornified envelope assembly and maintenance of barrier
function. An example of abnormal function of TG1 is lamellar
ichthyosis, a serious disease in which patients display a
thickened scaled epidermis (Huber et al., 1995). TG1 activity
is increased by the presence of calcium ions (Hennings et al.,
1981; Kasturi et al., 1993; Nemes and Steinert, 1999), but
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TG1, unlike other transglutaminases, does not have GTPase
activity and is not regulated by guanine nucleotides (Ahvazi
et al., 2002; Ahvazi and Steinert, 2003; Candi et al., 2004).
Addition of calcium to cell-cultured medium results in
increased intracellular calcium and increased TG1 activity
(Kruszewski et al., 1991). Expression of TIG3 also increases
TG1 activity (Sturniolo et al., 2003, 2005); however, TIG3 is a
unique regulator in that it activates TG1 in the absence of
added extracellular calcium (Sturniolo et al., 2003, 2005).
Because TIG3 is expressed in the suprabasal epidermal
layers, in the same epidermal layers as TG1, it is critical to
understand how TIG3 regulates TG1 activity. In this study, we
show that the TIG3 carboxy-terminal (C-terminal) region,
including amino acids 112–164, mediates TIG3 membrane
anchoring and interaction with TG1. We also present
surprising data, which indicate that the N-terminal TIG3
domain is required for TIG3 to stimulate keratinocyte
differentiation, as removal of this domain converts TIG3
from a pro-differentiation regulator to a proapoptosis
regulator.
RESULTS
Association of TIG3 mutants with TG1
We previously demonstrated that wild-type TIG31–164 asso-
ciates with TG1, induces transglutaminase activity, and serves
as a TG1 substrate (Sturniolo et al., 2003, 2005). Several TIG3
amino-acid sequence motifs, present in the N-terminal
hydrophilic segment, are conserved among members of the
H-Rev-107 family of tumor suppressors (Deucher et al.,
2000). These include the N-terminal homology domain
(amino acids 8–48) (Deucher et al., 2000), the NCEHFV
motif, and the LRYG motif (Figure 1a). We hypothesized that
one or more of these motifs may be required for interaction
with TG1. To test this hypothesis, we infected keratinocytes
with adenoviruses encoding TIG3 mutants, in which the
N-terminal end is progressively shortened. We then exam-
ined the ability of each TIG3 mutant to interact with TG1-
FLAG. Since the primary epitope detected by our TIG3
antibody is located between amino acids 41 and 100
(unpublished), we included hemagglutinin (HA) epitopes on
the N-terminus of the indicated TIG3 mutants to assure
detection. Extracts from TIG3 and TG1-FLAG expressing cells
were FLAG-immunoprecipitated and the precipitates were
monitored for the presence of TIG3 using anti-TIG3 or anti-
HA antibody. As shown in Figure 1b, TG1 is detected in all
cell lines infected with tAd5-TG1-FLAG, and detection using
anti-TIG3 or anti-HA confirms that TIG31–164 (wild type),
TIG341–164, TIG3100–164 and TIG31–134 are also expressed
(Figure 1b).
Incubation with anti-FLAG to precipitate FLAG-TG1
results in the co-precipitation of TIG31–164 (detected using
anti-TIG3), and TIG341–164 and TIG3100–164 (detected using
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Figure 1. The N-terminal homology domain is not required for TIG3 interaction with TG1. (a) A schematic presentation of the TIG3 forms. Regions of sequence
homology shared by TIG3 and other members of the hRev-107 family are represented as vertical bars. The N-terminal homology domain, the NCEHFV
and LRYG motifs, and the C-terminal hydrophobic tail are indicated. (b) Keratinocytes were infected with 20MOI of TIG3 adenovirus and 5MOI of
tAd5-TG1-FLAG, in the presence of 5MOI of Ad5-TA. At 24 hours post-infection, the cells are lysed and one-tenth portion of the total lysate was analyzed by
immunoblot for TG1-FLAG (anti-FLAG, upper panel), TIG3 (anti-TIG3 or anti-HA, lower panel), and b-actin. Anti-TIG3 was used to detect TIG31164 (wt)
and TIG31134, whereas anti-HA was used to detect the HA-tagged proteins, TIG3100164 and TIG341164. (c) TG1-FLAG was precipitated from the remaining
nine-tenth portion of lysate. TG1-FLAG was precipitated with anti-FLAG and TIG3 was detected in the precipitate by immunoblot with anti-TIG3 or anti-HA.
The arrow indicates the position of the interface between the stacking and running gels, m indicates TIG3 monomer, and the asterisk identifies
high-molecular-weight complexes containing crosslinked TIG3.
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anti-HA) (Figure 1c). It is interesting that the TIG3 forms that
are precipitated include monomer (m) and higher-molecular-
weight forms (*). In contrast, TIG31–134 is not precipitated. We
also tested TIG3112–164 and TIG3124–164 mutants; however,
these did not consistently co-precipitate with TG1-FLAG (not
shown). Thus, these studies suggest that the TIG3 motif
responsible for interaction with TG1 is located within the
segment spanning TIG3 amino acids 100–164 and that the
conserved N-terminal domain is not required.
To further examine the properties of these mutants, we
assessed whether each can function as a TG1 substrate. Cells
were infected with each of the TIG3 encoding adenoviruses
and at 48 hours post-infection the expressed TIG3 forms were
detected by immunoblot. As shown in Figure 2, monomers
(m) of TIG31–164, TIG341–164, TIG31–134 (Figure 2a), and
TIG3100–164 and TIG3112–164 (Figure 2b) are detected at the
correct size. In addition to the TIG3 monomers, higher-
molecular-weight anti-TIG3 or anti-HA-immunoreactive
forms, detected in the separatory and/or stacking gels, are
present. In contrast to the other mutants, TIG31–134, which
lacks the C-terminal hydrophobic domain (Sturniolo et al.,
2003, 2005), is not present as high-molecular-weight forms, a
finding that is consistent with the data in Figure 1b showing
that TIG31–134 does not interact with TG1. The presence of
high-molecular-weight, covalently crosslinked forms of
TIG341–164, TIG3100–164, and TIG3112–164 is consistent with
the functioning of these TIG3 mutants as TG1 substrates. We
were not able to consistently detect TIG3124–164 by immuno-
blot and, therefore, could not directly assess its ability to
interact with TG1 or function as a TG1 substrate. Although it
displays high biological activity and can be detected using
epifluorescence (see below), it may be unstable in extracts.
To confirm that the high-molecular-weight bands are formed
via the action of transglutaminase, we treated TIG3 mutant
expressing cells with monodansylcadaverine, a cell-perme-
able transglutaminase-competitive substrate inhibitor (Oliver-
io et al., 1997; Singh et al., 2003). Treatment with 50 mM
monodansylcadaverine reduces the formation of high-mole-
cular-weight wild-type TIG31–164, TIG341–164, TIG3100–164,
and TIG3112–164 containing complexes (not shown). Taken
together, these data indicate that TIG341–164, TIG3100–164, and
TIG3112–164 serve as transglutaminase substrates. The ob-
servation that TIG3112–164 is present as part of a high-
molecular-weight complex suggests that the TIG3 motif
required for interaction with TG1 is present within a 52-
amino-acid segment spanning TIG3 amino acids 112–164.
Ability of TIG3 mutants to promote fluorescent cadaverine
incorporation
The above evidence, indicating that the various TIG3 forms
interact with TG1 and function as TG1 substrates, suggests
that these mutants activate TG1. To test this hypothesis, we
expressed each TIG3 mutant in keratinocytes and monitored
their ability to promote covalent incorporation of fluorescein
cadaverine (FC). FC is a soluble fluorescent-tagged TG1
substrate that is covalently attached to cellular structures in
the presence of TG1 activity (Sturniolo et al., 2003). At
44 hours post-infection, the cells were treated with 100 mM FC
for 4 hours and then fixed and processed for fluorescent
microscopy. As shown in Figure 3, all of the mutants are
expressed (red fluorescence). Moreover, for each mutant, the
green fluorescent signal indicates FC incorporation. It is
particularly interesting that the distribution of each TIG3
mutant exactly mirrors the intracellular FC distribution. These
findings suggest that all of the TIG3 mutants are able to
increase transglutaminase activity. Since the exception is
TIG31–134, which is known not to interact with TG1 (Sturniolo
et al., 2005), these findings imply that all of the TIG3 mutants
interact with TG1. Assuming that activation requires interac-
tion, these results confirm that the TIG3 amino acids required
for TG1 interaction is located in the C-terminal region within
amino acids 112–164. These findings further suggest that the
TIG3 amino acids that participate in TG1-dependent cross-
link formation are located in this segment.
TIG3 does not alter TG1 palmitoylation
The TIG3 protein shares regions of sequence homology with
the enzyme lecithin retinol acyl transferase (Jahng et al.,
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Figure 2. TIG3 N-terminal truncation mutants form crosslinked multimers.
(a) Keratinocytes were infected with 20MOI of the indicated adenovirus in
the presence of 5MOI of Ad5-TA. At 48 hours post-infection, the cells
were lysed and analyzed for expression of TIG3 by immunoblot using
anti-TIG3 (top panel) or anti-HA (bottom panel). The asterisk indicates
high-molecular-weight TIG3-immunoreactive complexes. The arrow indicates
the junction between the stacking and separatory gels, and m indicates
migration of the TIG3 monomer. (b) Keratinocytes were infected as above and
at 48 hours post-infection the cells were lysed and analyzed for expression of
TIG3 by immunoblot using anti-HA (bottom panel). b-Actin levels were
monitored in each experiment as a loading control. These results are
representative of three repeated experiments.
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2003). Lecithin retinol acyl transferase has multiple
enzymatic functions, including palmitoylation activity
(Xue and Rando, 2004). Since a membrane anchor is added
to TG1 by palmitoylation, and since membrane association
influences TG1 function (Steinert et al., 1996), we investi-
gated whether TIG3 may regulate palmitoylation of TG1. To
examine this possibility, we expressed TG1-FLAG in keratino-
cytes in the presence or absence of TIG3. At 44 hours post-
infection the cells were pulsed with 14C-labeled palmitic acid
for 4 hours and incorporation of the palmitate into immuno-
precipitated TG1-FLAG was monitored by autoradiography.
We first confirmed, by immunoblot, that TG1-FLAG and
TIG3 are expressed (Figure 4a). We next monitored the
amount of 14C label present in immunoprecipitated TG1-
FLAG. As shown in Figure 4b, 14C-labeled palmitate is
incorporated into TG1-FLAG; moreover, the level of incor-
poration is not influenced by TIG3. The control lanes confirm
that no signal is present in cells that are not expressing TG1-
FLAG. Thus, it is unlikely that TIG3 influences palmitate
incorporation into TG1.
TIG3 is expressed in reconstructed epidermis,
localizes to the most differentiated layers, and is present in
high-molecular-weight complexes
Our findings clearly suggest that TIG3 and TG1 must interact
for TIG3 to regulate TG1 activity. Thus, if TIG3 is to be an
in vivo regulator of TG1 activity, TIG3 and TG1 must be
expressed in the same epidermal layers. In epidermis in vivo,
TG1 is detected within the upper spinous and granular layers
(Michel and Demarchez, 1988). TIG3 has also been
described as being localized in the suprabasal layers in
epidermis (DiSepio et al., 1998; Duvic et al., 2000, 2003).
However, TIG3 has not been detected in cultured keratino-
cytes—we believe because prolonged exposure efficiently
kills cells (Sturniolo et al., 2003, 2005). To confirm an
association of TIG3 and TG1 using an in vitro model, we
have used an epidermal raft system (Poumay et al., 2004). In
this model, keratinocyte progenitor cells are seeded onto a
semi-porous membrane. After 14 days, these cells form a
highly stratified and differentiated epidermis (Poumay et al.,
2004). Indeed, as shown in Figure 5a, this system forms a
EV
1-164
41-164
100-164
112-164
124-164
1-134
Figure 3. TIG3 regulates TG1 activity in situ. Keratinocytes were infected with 20MOI of the indicated adenovirus in the presence of 5MOI of Ad5-TA.
At 44 hours post-infection, the cells were incubated for 4 hours at 371C with 100mM of the cell-permeable fluorescent TG1 substrate, FC. After the incubation,
the cells were washed to remove non-crosslinked FC and fixed. TIG3 protein distribution was detected by epifluorescence (red) using anti-TIG3 (TIG31164,
TIG31134) or anti-HA (all others). Incorporation of FC was monitored in parallel (green) by epifluorescence microscopy. The arrows indicate the presence
of TIG3 (red) and FC incorporation (green) into perinuclear vesicles. No TIG3 signal was detected in empty vector-infected cells (EV), using either anti-TIG3 or
anti-HA (not shown). Similar results were observed in each of three experiments. Bar¼ 25 mM. Cells expressing the various TIG3 constructs were selected to show
the early stages of cell death.
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well-differentiated multilayered epidermis. Using this system,
we were able to identify TIG3 expression by immunoblot and
by epifluorescence labeling. By immunoblot, TIG3 monomer
(arrow) is detected in extracts derived from cells maintained
in the raft system (Figure 5b). This monomer corresponds in
size to that detected in keratinocytes cultured on plastic
following infection with tAd5-TIG31–164 (KER). Interestingly,
higher-molecular-weight TIG3-immunoreactive bands are
detected in extracts of cells from the raft cultures (*),
suggesting that TIG3 is covalently crosslinked in this system.
Immunohistological staining of the stratified epidermal
equivalent reveals a normal suprabasal pattern of involucrin
expression (Figure 5c). TIG3-specific immunofluorescence is
detected within the granular and lower cornified layers
(Figure 5c). This pattern of TIG3 expression overlaps with the
distribution of epidermal transglutaminase (Michel and
Demarchez, 1988). Thus, this finding is consistent with the
hypothesis that TIG3 functions to regulate TG1 activity.
N-terminal TIG3 mutants induce keratinocyte apoptosis
As mentioned above, several TIG3 amino-acid motifs, present
in the N-terminal hydrophilic segment, are homologous to
the corresponding region of other members of the H-Rev-107
family of tumor suppressors (Deucher et al., 2000). These
include the N-terminal homology domain, and the NCEHFV,
and LRYG motifs (Figure 1a). In the course of these studies,
we noticed that expression of several of these mutants
produced an altered keratinocyte phenotype, which we then
studied in detail. As shown in Figure 6, expression of wild-
type TIG31–164 induces a differentiation-like phenotype
characterized by the appearance of a flattened and scale-
like morphology. We have previously shown that these
structures survive boiling in reducing agent and detergent and
display properties of cornified envelopes (Sturniolo et al.,
2003, 2005). The phenotype produced by TIG341–164 and
TIG3100–164 appears similar to that observed with TIG31–164,
except that the number of rounded and detached cells is
increased. In contrast, the TIG3112–164 and TIG3124–164
mutants produce a distinctly different morphology in that
the cells release from the substrate, assume a rounded
morphology, and form blebs and transparent vesicles. The
presence of large transparent vesicles is a particularly
apparent feature of this phenotype (arrows; Figure 6). This
morphology resembles a previously described apoptotic
phenotype (Efimova et al., 2004). The number of transparent
vesicles increases with time in cultures that express
TIG3112–164 or TIG3124–164. These structures are only rarely
detected in cultures expressing wild-type TIG3 or other TIG3
mutants. A rare such example is shown by the arrow in the
expanded panel of TIG341–164. As expected from our previous
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Figure 4. TIG3 does not regulate palmitoylation of TG1. Keratinocytes were
infected with 20MOI of tAd5-EV or tAd5-TIG3 in the presence of 5MOI of
tAd5-TG1-FLAG and 5MOI of Ad5-TA. At 44 hours post- infection, the cells
were incubated with [1-14C]palmitic acid in fresh KSFM at 1mCi/ml in 3ml of
KSFM for 4 hours (final concentration¼ 17.5 mM). (a) TG1-FLAG and TIG3 are
expressed in keratinocytes. Extracts were prepared from cells following
incubation with 14C-labaled palmitic acid. Total extract was electrophoresed
on a 10% polyacrylamide gel for immunoblot with anti-TG1 to detect
TG1-FLAG, and anti-TIG3 to detect FLAG-TIG3. b-Actin was included as a
normalization control for protein loading. (b) TIG3 does not alter the level of
14C-labeled palmitate incorporation in TG1-FLAG. Cells were incubated with
virus and 14C-labeled palmitic acid as outlined above. Total cells extracts
were prepared in lysis buffer and TG1-FLAG with precipitated using
agarose-conjugated anti-FLAG antibody (Sturniolo et al., 2005). Precipitated
protein was electrophoresed on a 10% polyacrylamide gel and the gel was
fixed, dried, and exposed for detection of TG1-associated [1-14C]palmitate.
The arrow indicates the position of the 14C-palmitate-labeled TG1-FLAG.
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Figure 5. TIG3 is expressed in differentiated layers. Epidermal tissue
equivalents were prepared on polycarbonate filters (Poumay et al., 2004).
(a) After exposure at the air–liquid interface, the equivalents were fixed,
dehydrated, and embedded in paraffin before preparation of 5 mM sections and
hematoxylin &eosin staining. (b) Equivalents were lysed by sonication directly
into Laemmli buffer and the 50mg of total extract was electrophoresed on a
12% gel for immunoblot with anti-TIG3 (raft). The parallel lane contains
extract prepared from keratinocytes expressing adenovirus-delivered
TIG31164 (KER). b-Actin level was measured as an internal normalization.
(c) Sections were prepared and analyzed for TIG3 expression by
immunofluorescence. Sections were incubated with rabbit-anti-TIG3
followed by an appropriate secondary antibody. The membrane is indicated
(m), as is the extent of the epidermis (Epi). The control section was treated
with secondary antibody alone. Fluorescence was detected by
epifluorescence microscopy.
www.jidonline.org 521
R Jans et al.
TIG3—a Multifunctional Regulator
study, keratinocytes infected with empty vector (EV) or with a
virus encoding a TIG3 mutant that lacks the C-terminal
hydrophobic membrane-anchoring domain exhibit a normal
phenotype (Deucher et al., 2000). We performed parallel
experiments to monitor cell viability in these cultures. As
compared with the empty vector-infected cells (100%), the
average percentage of viable cells, as measured by trypan
blue exclusion, for three experiments is 4272% (TIG31–164),
2873% (TIG341–164), 2075% (TIG3100–164), 2273%
(TIG3112–164), and 1972% (TIG3124–164) at 48 hours of
treatment. Additional death is observed at longer periods of
time. The death occurs via two distinct pathways depending
upon the TIG3 isoform. TIG31–164 (full length) causes
differentiation-related cell death, whereas the TIG3112–164
and TIG3124–164 mutants cause apoptosis. TIG31–134 does not
reduce cell viability. The presence of the HA epitope on some
of the mutants does not have an impact, as non-tagged
proteins produce a similar phenotype (not shown).
Loss of N-terminal conserved domains converts TIG3 to a
proapoptotic protein
In keratinocytes, apoptosis is characterized by breakdown of
mitochondrial membrane potential, the release of cyto-
chrome c, formation of the apoptosome, and activation of
caspases and poly(ADP-ribose)polymerase (PARP) (Teraki
and Shiohara, 1999; Gandarillas, 2000; Sitailo et al., 2004).
Therefore, we analyzed the effect of expression of the TIG3
mutants on cytochrome c release, and cleavage of procas-
pase-3 and PARP. To assess the impact on cytochrome c
release from mitochondria into the cytoplasm, keratinocytes
were infected with adenoviruses encoding TIG31–164,
TIG31–134, and TIG3124–164. After 48 hours, the cells were
harvested for subcellular fractionation. As shown in Figure
7a, no cytoplasmic cytochrome c is observed for cells
expressing TIG31–164 or TIG31–134. In contrast, substantial
cytoplasmic cytochrome c is detected TIG3124–164 expressing
cells. This finding suggests that the TIG3124–164 mutant causes
a loss of mitochondrial membrane potential, leading to
release of cytochrome c. This suggests that the apoptosis is
mitochondria-dependent. In keratinocytes, apoptosis is fre-
quently associated with a change in the Bax/Bcl-xL ratio,
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Figure 6. TIG3 mutants differentially regulate cell morphology. Cultured normal human keratinocytes were infected with 20MOI of tAd5-EV (EV, empty
vector), tAd5-TIG31–164 (full length), tAd5-TIG341–164, tAd5-TIG3100–164, tAd5-TIG3112–164, tAd5-TIG3124–164, or tAd5-TIG31–134, in the presence of 5MOI of
Ad5-TA. At 48 hours post-infection, the cultures were photographed by phase-contrast microscopy. Similar results were observed for the TIG3 mutants in
constructs lacking the HA epitope (not shown). Bar¼ 25 mM.
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Figure 7. TIG3 N-terminal truncation mutants promote cytochrome c
release from mitochondria. (a) Keratinocytes were infected with 20MOI of
tAd5-EV (EV, empty vector), tAd5-TIG31–164 (full length), tAd5-TIG3124–164, or
tAd5-TIG31–134, in the presence of 5MOI of Ad5-TA. At 48 hours post-
infection, the cells were fractionated and mitochondrial and cytoplasmic
cytochrome c levels were measured. Cytochrome c oxidase subunit IV, which
is constitutively associated with the mitochondrial fraction, was monitored as
a control. Sample fractions were collected from the mitochondrial (m) and
cytosol (c). (b) Cytochrome c release is not associated with a change in the
Bax/Bcl-xL ratio. Keratinocytes were treated as above and total extracts were
prepared for immunoblot detection of Bax, Bcl-xL, and b-actin.
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which is associated with compromised mitochondrial integ-
rity and enhanced release of cytochrome c (Jost et al., 1999,
2001). To determine whether a change in this ratio is a
possible mechanism for the increased cytochrome c release,
we monitored Bax and Bcl-xL level by immunoblot. As
shown in Figure 7b, TIG3124–164 expression does not alter the
level of Bax or Bcl-xL.
Cytochrome c release in the cytoplasm is known to trigger
activation of the caspase cascades. To assess this possibility
and to study the apoptotic process in greater detail,
keratinocytes were infected with TIG3 encoding viruses.
After 48 hours, the cells were harvested and extracts were
assayed for presence of the procaspase-3 and PARP cleavage
products. As shown in Figure 8a, no change in procaspase-3
or PARP cleavage was observed following expression of wild
type TIG31–164, or the TIG341–164 of TIG31–134 mutants. In
contrast, TIG3112–164 and TIG3124–164 produces a marked
increase in procaspase-3 and/or PARP cleavage. These
findings, taken together with the morphological changes
indicated in Figure 6 and the cytochrome c release shown in
Figure 7, strongly suggest that the two truncation mutants,
TIG3112–164 and TIG3124–164, drive keratinocyte apoptosis.
Because these mutants also reduce cell proliferation (not
shown), we examined their impact on the level of the cell
cycle regulatory proteins, p53 and p21—two proteins that are
key regulators of cell cycle (Grana and Reddy, 1995;
McGowan, 2003). Figure 8b indicates that the TIG3124–164
mutant, the strongest inducer of apoptosis, suppresses p53
and p21 levels. This is a surprising finding, since p53 and p21
levels are usually increased in cells as they cease cell
proliferation; however, some studies have reported the loss of
these proteins in stressed cells (Qu et al., 2004; Pluquet et al.,
2005). It is important to note that TIG3124–164 produces a
dramatic change in phenotype, despite the fact that it is
expressed at vanishingly low levels. The magnitude of the
response, coupled with the low level of expression, suggests
that TIG3124–164 is a potent inducer of apoptosis.
The proapoptotic action of the TIG3 mutants is associated with
a change in intracellular location
The proapoptotic action of TIG3112–164 and TIG3124–164 as
compared with TIG31–164 (wild type) could be caused by a
change in distribution of mutant versus wild-type TIG3 and
may reflect the enhanced hydrophobic character of the
protein. To explore this possibility, individual TIG3 forms
were expressed in keratinocytes and distribution was assessed
by epifluorescent microscopy. Consistent with our previous
reports showing that endogenous TIG3 is not expressed in
normal human keratinocytes maintained as monolayer
cultures (Sturniolo et al., 2003, 2005), no TIG3 immuno-
fluorescence is detected in cells infected with empty vector
(EV) (Figure 9). Full-length TIG3 is detected in a typical
distribution—in perinuclear structures and diffusely in the
cytoplasm of cells infected with TIG31–164 encoding adeno-
virus. However, truncation of TIG3 produces a marked
change in distribution, which is dependent upon the extent of
reduction in length of the N-terminus. TIG341–164, for
example, is distributed in perinuclear location with much
less diffuse staining. However, the most striking shift in
distribution is observed with TIG3100–164, TIG3112–164 and
TIG3124–164 which display a very punctate perinuclear
staining pattern with little or no diffuse staining. These
studies suggest that the redistribution of TIG3 to a punctate
perinuclear distribution is associated with enhanced apopto-
sis. As anticipated, TIG31–134, which lacks the C-terminal
membrane-anchoring domain, displays a diffuse pattern of
staining (Sturniolo et al., 2003). Interestingly, this mutant is
not biologically active—either as an inducer of differentiation
or apoptosis.
To assess the mechanism responsible for this change in
distribution, we cloned full-length TIG31–164 or the 40-amino-
acid segment present in TIG3134–164, at the N-terminus of
GFPN1 (Figure 10a). We then expressed each protein in
keratinocytes and compared the subcellular distribution. As
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Figure 8. N-terminal truncation converts TIG3 into a proapoptotic protein.
Keratinocytes were infected with 20MOI of tAd5-EV (EV, empty vector),
tAd5-TIG31–164 (full length), tAd5-TIG341–164, tAd5-TIG3112–164,
tAd5-TIG3124–164, or tAd5-TIG31–134, in the presence of 5MOI of Ad5-TA.
(a and b) At 48 hours post-infection, the cells were lysed and analyzed for
expression of TIG3 (anti-HA or anti-TIG3), procaspase-3, and PARP cleavage
products, and level of p53 and p21WAF1/CIP1 expression. b-Actin levels were
monitored as an internal loading control. Shown is a representative result of
three independent experiments. The asterisks indicate procaspase-3 and PARP
cleavage products.
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shown in Figure 10b, each of the proteins is expressed in
keratinocytes and can be detected by anti-green fluorescent
protein (GFP) immunoblot. To examine the impact of the
mutants on subcellular distribution, we expressed each
protein in keratinocytes and COS7 cells, and then monitored
the distribution in membrane and soluble fractions. These
findings indicate that in keratinocytes and COS7 cells less
than 5% of GFP distributes in the particulate fraction (Figure
10c). For TIG31–164-GFP the particulate-associated material
increases to 15–25%. However, removing additional amino
acids from TIG3, to create TIG3134–164-GFP, results in an
increase in membrane localization to 80–90%. Figure 10d
shows the intracellular distribution of GFP and TIG3-GFP
fusion proteins in COS7 cells. GFP is distributed throughout
the cell. In contrast, TIG31–164-GFP is distributed in a pattern
that resembles the one observed for wild-type TIG3.
TIG3134–164-GFP, which encodes only the C-terminal mem-
brane-anchoring domain fused to GFP, is more strongly
punctate. These findings are consistent with the idea that
ability of the TIG3112–164 and TIG3124–164 mutants to cause
cell death is associated with increased distribution of TIG3
into the particulate fraction.
DISCUSSION
Transglutaminases comprise a family of enzymes that are
important in a wide range of tissue remodeling processes
ranging from blood coagulation to assembly of epidermal
structures (Lorand and Graham, 2003). A primary role of
these enzymes is catalyzing the formation of protein–protein
crosslinks (Goldsmith and Martin, 1975; Ogawa and
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Figure 10. The C-terminal domain regulates the subcellular distribution of
TIG3. (a) The structures of TIG31–164, GFPN1, TIG31–164-GFPN1, and
TIG3134–164-GFPN1. (b) Keratinocytes (1 160 cm2 dish) were transfected
with the indicated expression plasmid and at 24 hours post-transfection, the
cells were washed with PBS, collected by scraping, and homogenized in 1ml
of lysis buffer (10mM HEPES, pH 7.4, 1mM EDTA, 1mM dithiothreitol,
10mg/ml polymethylsulfonyl fluoride). The extract was centrifuged at
100,000 g for 30minutes to yield the supernatant (cytosol) and the pellet
(particulate) fractions. The distribution of the fusion protein in cytosol versus
particulate fraction was assessed by electrophoresis of the separated fractions
and detection of the fusion proteins using anti-GFP. The migration of the
monomer (m) and crosslinked multimers (arrow) is indicated (representative
of four experiments). b-Actin is shown as a loading control in the lower panel.
(c) The percent of anti-GFP signal in the particulate fraction was assessed by
densitometric scanning (NIH ImageJ program, http://rsb.info.nih.gov/ij/) of
immunoblots. The results are representative of two independent experiments
per cell type (keratinocytes and COS7 cells). (d) COS-7 cells were transfected
with the indicated expression vector and at 24 hours post-infection, the cells
were observed using brightfield and epifluorescent microscopy (green). The
arrows indicate the border of the nucleus. The bar indicates the cell size for all
panels. Bar¼ 25 mM.
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Figure 9. N-terminal truncation alters the subcellular distribution of TIG3.
Keratinocytes were infected with 20MOI of each adenovirus in the presence
of 5MOI of Ad5-TA. At 24 hours post-infection, the cells were fixed and TIG3
localization was analyzed by epifluorescence microscopy. The arrows in
each brightfield image indicate the boarder of the nucleus. TIG31–164,
TIG341–164, and TIG31–134 were detected using anti-TIG3 (Deucher et al.,
2000); TIG3100–164, TIG3112–164, and TIG3124–164 were detected using anti-
HA. No signal was observed with anti-TIG3- or anti-HA in empty vector
(EV)-infected cells. The photographs show cells that are representative of all
cells in the field for four independent experiments. The bar indicates the cell
size for all panels. Bar¼ 25mM.
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Goldsmith, 1976; Huber et al., 1995). In the epidermis, this
process leads to assembly of the cornified envelope
(Robinson et al., 1997; Nemes and Steinert, 1999). Keratino-
cytes produce several types of transglutaminase; however,
the most important member of this family in epidermis is
TG1, which is attached to the inner surface of the
plasma membrane via a lipid anchor (Phillips et al., 1993;
Steinert et al., 1996). Transglutaminase is expressed in the
suprabasal epidermal layers and activation occurs during
the terminal stages in keratinocyte differentiation.
Envelope assembly initiates with the covalent crosslinking
of soluble membrane precursors, including involucrin,
and the subsequent addition of insoluble precursors (Eckert
et al., 1993, 2005; Steinert, 1995). The absence of normal
activation of TG1 leads to epidermal barrier function
diseases, including the scaling disease, lamellar ichthyosis
(Huber et al., 1995; Hohl et al., 1998). TG1 function
requires two distinct processes—first, TG1 must be expressed
in the appropriate location in the epidermis, a process
that is mediated by regulatory sequences upstream of the
gene (Phillips et al., 2004), and second, catalytic activity
must be activated at the appropriate time. The latter
process requires the binding of calcium to transglutaminases
in order to activate crosslinking (Ahvazi et al., 2004).
Numerous studies have shown that adding extracellular
calcium to keratinocyte cultures leads to increased levels of
intracellular calcium and activation of TG1 (Hennings et al.,
1981, 1989; Kasturi et al., 1993). Because of the importance
of this enzyme in the normal differentiation process, under-
standing the mechanisms that regulate TG1 is an important
goal.
Until recently, calcium was the only agent known to
regulate TG1 activity. Recently we identified a novel protein
regulator of TG1 activity, called TIG3 (DiSepio et al., 1998).
Our previous studies indicate that TIG3 protein cannot be
detected in cultured normal human keratinocytes maintained
in monolayer culture (Sturniolo et al., 2003, 2005). Thus, as a
method to study TIG3 function in cultured cells, we
established TIG3 expression in keratinocyte cultures using
adenovirus delivery. Our recent studies show that TIG3
expression results in the activation of differentiation-like cell
death that is associated with activation of TG1 and the
formation of cornified envelope-like structures, and that the
response is inhibited by transglutaminase competitive sub-
strate inhibitors (Sturniolo et al., 2003, 2005). Important
features of this response are that it does not involve activation
of apoptosis-associated cell death and does not require
addition of extracellular calcium (Sturniolo et al., 2005). The
TIG3 C-terminal hydrophobic membrane-anchoring domain
(amino acids 134–164) is required for activity, since
TIG31–134, a mutant that lacks this domain, is completely
inactive (Deucher et al., 2000; Sturniolo et al., 2005). The
C-terminal domain is also required for TIG3 (RIG1) function
in other systems (Tsai et al., 2006). An important additional
fact is that TIG3 binds to transglutaminase and that this
interaction is required for the TIG3-dependent increase in
TG1 activity (Deucher et al., 2000; Sturniolo et al., 2003,
2005).
The absence of TIG3 expression in monolayer cultures of
normal human keratinocytes suggests that specific differen-
tiation-associated cues may be required for TIG3 expression
(Sturniolo et al., 2003, 2005). Moreover, our studies suggest
that an absence of TIG3 expression may be necessary for
cultured keratinocyte survival, since forced expression of
TIG3 causes keratinocyte terminal differentiation (Sturniolo
et al., 2003, 2005). To confirm that TIG3 indeed can be
expressed in cultured cells, we used a raft culture system in
which the epidermis is reconstructed on polycarbonate filters
(Poumay et al., 2004). In this system, a completely layered
epidermis was formed that expressed the differentiation
marker, involucrin, in the suprabasal layers. In addition,
TIG3 is detected in the most differentiated epidermal layers.
This expression pattern mimics that observed in vivo in adult
epidermis (Duvic et al., 2000) and confirms that TIG3
expression (granular and cornified layers) is associated with
a zone of maximal TG1 activity in vivo. Moreover, it
indicates that in vitro TIG3 expression is strictly associated
with cells undergoing terminal differentiation (i.e., TIG3
expression is not consistent with cell survival).
TIG3 interaction with TG1 requires the C-terminal region
A major goal of this study was to characterize the TIG3
domain(s) responsible for interaction with TG1. These studies
indicate that TG1 interacts with a TIG3 motif located within
amino acids 124–164, a region that includes the hydrophobic
membrane-anchoring domain (amino acids 134–164) and 10
additional residues (amino acids 124–133). It is particularly
interesting that these regions do not include the highly
conserved motifs present in the N-terminal segment of the
protein. In addition to activating TG1, these mutants also
served as TG1 substrates, suggesting that lysine and
glutamine residues present in this sequence are TG1 targets.
TIG3—differentiation versus apoptosis
The finding that the N-terminal conserved regions are not
required for interaction with TG1 suggests that they may have
other functions. This was evident by the altered phenotype
observed for the TIG3 truncation mutants. Wild-type TIG3
induces a keratinocyte differentiation-like phenotype, in
which keratinocytes adopt a flattened, scale-like shape and
produce detergent and reducing agent-insoluble crosslinked
structures resembling cornified envelopes (Sturniolo et al.,
2003). In contrast, removal of the N-terminus converts TIG3
from a pro-differentiation to a proapoptosis protein. The
proapoptosis phenotype is observed for mutants including
TIG3100–164, TIG3112–164, and TIG3124–164, but the most
dramatic proapoptosis phenotype is observed for
TIG3112–164 and TIG3124–164 (Table 1). The TIG3 mutant-
associated apoptosis is manifest as cell rounding, membrane
blebbing, and formation of large translucent vesicles.
Biochemical assays reveal that this process is associated with
mitochondrial release of cytochrome c and cleavage of
procaspase-3 and PARP, known effectors of apoptosis (Adrain
and Martin, 2001; Adams and Cory, 2002), suggesting that
TIG3 promotes apoptosis via a mechanism that involves loss
of mitochondrial integrity. Previous reports indicate that
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under specific conditions, loss of keratinocyte mitochondrial
integrity is associated with an increase in the Bax/Bcl-xL ratio
(Jost et al., 1999, 2001). However, our studies show that this
ratio is not altered by the proapoptosis TIG3 mutants,
indicating that a simple change in the ratio of these
proapoptotic (Bax) versus anti-apoptotic (Bcl-xL) regulators
is not the cause of apoptosis.
It is possible that removal of the upstream amino acids in
TIG3 exposes domains that function to promote apoptosis.
However, this possibility appears somewhat unlikely, as it
does not readily explain the progressive shift to a stronger
apoptosis phenotype as the protein is truncated (i.e.,
TIG3124–164, is the most pro-apoptotic form). Removal of
the N-terminal segment of TIG3 results in a shift in the
distribution of the TIG3 protein such that more TIG3 localizes
to the particulate phase and in perinuclear vesicles. TIG31–164
is 50% distributed in the membrane and 50% in the soluble
fraction. In contrast, the N-terminal truncation mutants
fractionate almost exclusively in the particulate (membra-
nous) fraction. It is of interest that the mutants are localized in
perinuclear vesicular structures. It may be that the mutants
localize to the membranous fraction due to the greater overall
hydrophobic character of the truncated protein. Thus, the
TIG3124–164 mutant may function by interfering with pro-
cesses in the membrane-associated vesicular compartment.
Our studies further show that the TIG3124–164 mutant, in
addition to activating caspases, also reduces p53 and p21
level. The reduction in p21 level is not surprising, since p21
expression is controlled by p53 (Li et al., 1994). However, the
reduction in p53 is somewhat surprising, since a major
function of p53 is to halt the cell cycle to permit time for
repair of intracellular DNA damage (Bunz et al., 1998), and
an increase in p53 expression frequently proceeds apoptosis.
The TIG3124–164 expressing cells are presumably lacking this
repair function. It is possible that p53 is selectively targeted
for degradation by TIG3124–164. p53 is known to be
destabilized in specific conditions, such as endoplasmic
reticulum (ER) stress, which involves E3 ubiquitin-ligase
(Mdm2) transport of p53 from the nucleus to cytoplasm and
subsequent p53 degradation in the proteasome (Qu and
Koromilas, 2004; Stavridi and Halazonetis, 2004; Pluquet
et al., 2005). ER stress is provoked by a range of stress stimuli
and can result in the accumulation of unfolded proteins in the
ER. The presence of unfolded proteins in the ER leads to cell
dysfunction (Breckenridge et al., 2003). Compensation
includes a regulated reduction in protein entry into the ER,
which presumably provides time for the system to remove the
unfolded proteins. It is thought that the ER stress-associated
reduction in p53 may function to slow apoptosis and permit
the cells time to correct the unfolded protein condition
(Qu et al., 2004; Pluquet et al., 2005). However, prolonged
uncorrected ER stress ultimately results in cell death. Thus,
the reduction in p53 observed in our studies may be due to a
TIG3124–164-induced ER stress response.
An important question is whether the truncated forms of
TIG3 may have a physiological role. We have not detected
TIG3 proteolytic cleavage products corresponding to the size
of the TIG3 truncation mutants, and thus do not know
whether the TIG3 truncated forms have a physiological role
in vivo. However, the important physiological insight derived
from the study of these mutants is that removal of the TIG3
N-terminus inactivates the TIG3 pro-differentiation function,
indicating that the N-terminus is required for the pro-
differentiation action of TIG3. It will be important in future
studies to further examine how this region contributes to this
pro-differentiation action.
MATERIALS AND METHODS
Cell culture
Human foreskin keratinocytes were cultured in 0.09mM calcium
containing keratinocyte serum-free medium (KSFM) (Sigma, St Louis,
MO). COS7 cells (Gluzman, 1981) were maintained in Dulbecco’s
modified Eagle’s medium (Invitrogen, Carlsbad, CA) containing 10%
fetal calf serum (Sigma). All studies were approved by the
Institutional Review Board of University Hospitals at Case Western
Table 1. TIG3 mutants—intracellular behavior and cell response
Protein
Increased TG1
activity
Cell morphology
response
Blebbing, sphere
formation,
PARP/caspase cleavage
Suppression of p53
and p21 expression
Subcellular
location
(particulate/
soluble)
TIG3(1–164) Yes Differentiation  No +++ +++
TIG3(41–164) Yes Apoptosis  No +++ +++
TIG3(100–164) Yes Apoptosis  No +++++ +
TIG3(112–164) Yes Apoptosis + No ++++++
TIG3(124–164) Yes Apoptosis +++ Yes ++++++
TIG3(1–134) No No response No response No ++++++
TIG3(1–164)-GFP NT NT NT NT +++ +++
TIG3(134–164)-GFP NT NT NT NT ++++++
GFP, green fluorescent protein; NT, not tested; PARP, poly(ADP-ribose)polymerase; TIG3, Tazarotene-induced gene 3.
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Reserve University, and the study was conducted in adherence with
the Declaration of Helsinki Principles.
Reagents and antibodies
Production of rabbit anti-TIG3 was previously described (Deucher
et al., 2000). Mouse anti-human b-actin was obtained from Sigma.
Mouse anti-TG1 was obtained from (Biomedical Technologies Inc.,
Stoughton, MA). Rabbit anti-GFP was purchased from Santa Cruz
(Santa Cruz, CA). Alexa Fluor 488-conjugated goat anti-mouse IgG
was from Molecular Probes (Carlsbad, CA). Cy3-conjugated sheep
anti-rabbit IgG was obtained from Sigma. Peroxidase-conjugated
donkey anti-rabbit IgG and peroxidase-conjugated sheep anti-mouse
IgG were purchased from Amersham Biosciences/GE (Piscataway,
NJ). Monodansylcadaverine, a competitive TG1 substrate, which
serves as a substitute amine donor to inhibit TG1 interaction with its
normal cellular substrates, was purchased from Sigma. Rabbit anti-
caspase-3 was purchased from Cell Signaling (Danvers, MA). Mouse
anti-PARP was obtained from BD Biosciences (San Jose, CA). Rabbit
anti-p21WAF1/CIP1, mouse anti-p53, and rabbit anti-GFP antibodies
were obtained from Santa Cruz.
Adenovirus infection
The tetracycline-regulated recombinant adenoviruses, tAd5-
TIG31–164 (full-length TIG3) and tAd5-TIG31–134 (C-terminal trunca-
tion), were previously described (Sturniolo et al., 2003, 2005).
Adenoviruses encoding HA-tagged N-terminal-truncated TIG3 mu-
tants, tAd5-HA-TIG341–164, tAd5-HA-TIG3100–164, tAd5-HA-
TIG3112–164, and tAd5-HA-TIG3124–164 were constructed by PCR
and the product was cloned into a shuttle vector, pDE1sp1Btet,
which was derived from pDE1sp1B (Bett et al., 1994). All sequences
were confirmed by DNA sequence analysis. The resulting plasmid
was then recombined with the adenovirus backbone plasmid,
pJM17, in 293 cells to create the corresponding tAd5 virus (Graham
et al., 1977; McGrory et al., 1988). tAd5 contains a tetracycline
operator-responsive element linked to the cytomegalovirus promo-
ter. This promoter is active in the presence of the tetracycline
transactivator (TA) protein, which is provided by co-infection with a
second adenovirus, Ad5-TA. The upstream primers for construction
of these mutants encode an EcoRI site and the downstream primer
encodes an XbaI site. The upstream primers include the following:
tAd5-TIG341–164 5
0-GCGAATTCTATGTACCCATACGACGTACCAG
ACTACGCAAGTGAGTACCCCGGGGCTGGC, tAd5-TIG3100–164
50-GCGAATTCTATGTACCC ATACGACGTACCAGACTACGCAGTT
GGTCAGAAGATGAAGTAC, tAd5-TIG3112–164 5
0-GCGAATTCTA
TGTACCCATACGACGTACCAGACTACGCAAACTGTGAGCACTTT
GTCACC, and tAd5-TIG3124–164 5
0-GCGAATTCTATGTACCCATAC
GACGTACCAGACTACGCAAAGTCCCGCTGTAA ACAGGTG. The
downstream primer was 50-CGTCTAGATCAGG CTGTTGCTTTTTT
TTGGTATC. The translation start codons in the upstream primers are
in bold. A FLAG-tagged TG1-encoding adenovirus, tAd5-TG1-FLAG,
was constructed using plasmid, pGEM-TG1, kindly provided by
Dr Robert Rice (UC Davis) (Phillips et al., 1990). An EcoRI/XhoI
fragment of TG1 was released from this plasmid and cloned
upstream of and in-frame of a linker-constructed sequence that
encodes the last four codons of TG1 and the FLAG epitope tag to
create pcDNA3-TG1-FLAG. The insert was then removed using
EcoRI/XbaI and cloned into pDE1sp1Btet. The resulting plasmid was
then recombined with the adenovirus backbone in 293 cells to
create tAd5-TG1-FLAG. An empty recombinant adenovirus, tAd5-
EV, was constructed for use as a control and a GFP-encoding
adenovirus, Ad5-GFP, was used to determine keratinocyte infection
efficiency. For infection, keratinocytes were incubated with varying
multiplicity of infection (MOI) of tAd5-TIG3 virus or tAd5-EV in the
presence of 5MOI of Ad5-TA for 24–48 hours in KSFM containing
2.5 mg polybrene/ml (Sigma). The cells were then shifted to fresh
virus-free KSFM for varying times before harvest.
TIG3 and palmitoylation of TG1
Cultures of near-confluent keratinocytes, growing in 20 cm2 dishes
in 3ml of KSFM, were infected with 20MOI of tAd5-EV or tAd5-
TIG3 in the presence of 5MOI of tAd5-TG1-FLAG and 5MOI of
Ad5-TA. At 44 h post-infection, the cells were incubated with
[1–14C]palmitic acid in fresh KSFM at 1mCi/ml (final concentra-
tion¼ 17.5mM) for 4 hours (Steinert et al., 1996). The cells were then
harvested and TG1-FLAG was precipitated using agarose-conjugated
anti-FLAG antibody (Sturniolo et al., 2005). Precipitated proteins
were electrophoresed on a 10% polyacrylamide gel, and the gel was
subsequently fixed, dried and exposed for 7 days in the presence of a
tritium phosphorimaging screen (Molecular Dynamics/GE, Piscat-
away, NJ) to detect radiolabel incorporation. The radiolabel was
detected using a Storm Imager (Molecular Dynamics/GE). The
[1–14C]palmitic acid was purchased from Amersham Biosciences
(cat. no. CFA23, 57mCi/mmol, 9.25MBq/1.25ml).
Cytochrome c release and detection of Bax and Bcl-xL
To monitor for cytochrome c release from the mitochondria,
mitochondrial and cytosolic fractions were separated by using an
ApoAlert cell fractionation kit (BD Biosciences/Clontech, San Jose,
CA) in accordance with the manufacturer’s instructions, and the
fractions were analyzed for the presence of cytochrome c by
immunoblotting with anti-cytochrome c antibody. The purity of the
fractions was monitored by measuring the level of cytochrome
c oxidase subunit IV, a constitutively associated mitochondrial marker.
Bax and Bcl-xL were detected by immunoblot with specific antibodies
(murine anti-Bax (6A7) (catalog number 556467), and rabbit anti-Bcl-
xL (catalog number 610211), both from BD Pharmingen (San Jose, CA).
Co-immunoprecipitation, immunoblot, and
immunofluorescence
Immunoprecipitation of FLAG epitopes and detection of TG1, TIG3,
and HA epitopes by immunoblot were performed as described
previously (Sturniolo et al., 2005). For immunofluorescence,
keratinocytes were infected with adenoviruses and at 24 hours
post-infection the cells were washed, fixed with 4% formaldehyde in
phosphate-buffered saline (PBS) for 30minutes and permeabilized
using PBS containing 0.1% Triton X-100 and 1% BSA for 30minutes.
The coverslips were then incubated for 1 hour with the appropriate
primary antibody, followed by the appropriate secondary antibody,
diluted in the same buffer. After washing, the samples were placed
onto slides using Mowiol 4–88 (Calbiochem, San Diego, CA) and
visualized by fluorescent microscopy using a Nikon Optiphot
fluorescence microscope.
Construction of TIG3-GFP fusion proteins
TIG31–164 and TIG3134–164 were amplified to include XhoI and
HindIII sticky ends by standard PCR methods using pcDNA3-
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TIG31–164 as template (Sturniolo et al., 2003, 2005). The TIG31–164
forward primer sequence was 50-GCCTCGAGATGGCTTCGCCACA
CCAAGAG. The TIG3134–164 forward primer sequence was 5
0-
GCCTCGAGATGGTTTGAAGTCGGTGTGGC. The common reverse
primer sequence was 50-GCAAGCTTGGCTGTTGCTTTTTTTTGG
TA. The ATG translation start codon is indicated in bold. To
construct TIG31–164-GFP and TIG3134–164-GFP expression vectors,
the fragments were then cloned into pEGFPN1 (Clontech/Takara Bio
Inc., Mountain View, CA) using the Rapid Ligation kit (Roche,
Indianapolis, IN). The correct sequence of the plasmids was verified
by DNA sequencing.
Fluorescent in situ detection of transglutaminase activity
Human keratinocytes, growing on coverslips, were treated with the
appropriate adenovirus for 24 hours, followed by addition of fresh
virus-free medium. At 44 hours post-infection, fresh KSFM contain-
ing 100 mM FC (catalog number A-10466; Molecular Probes) was
added for 4 hours (Sturniolo et al., 2003). The cells were then
washed with PBS and fixed with 100% methanol at 201C, washed
twice with cold methanol, and washed twice more with PBS before
placing the samples onto slides using Mowiol 4–88 for visualization
by fluorescent microscopy using a Nikon Optiphot fluorescence
microscope.
Transient transfection
For plasmid transfection, near-confluent cultures of COS7 cells
(50 cm2 dishes) were incubated with 10ml of Dulbecco’s modified
Eagle’s medium containing 3 mg DNA and 27 ml Fugene (Roche) for
24 hours. Keratinocytes growing in 156 cm2 dishes in 25ml KSFM
were transfected with 10 mg DNA and 68 ml Fugene, for 24 hours.
The cells were then harvested for detection of the plasmid-encoded
proteins.
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